![]() Runikhina, M.D., Ph.D., doctor of sciences, professor, deputy head of Gerontological Clinical Research Center, Pirogov Russian National Research Medical University, Moscow, Russia Yulia V. Dudinskaya, M.D., Ph.D., head of the laboratory of age-related, metabolic and endocrine abnormalities, Gerontological Clinical Research Center, Pirogov Russian National Research Medical University, Moscow, Russia ![]() Kalashnikov, M.D., Ph.D., doctor of sciences, professor, corresponding member of the Russian Academy of Sciences, head of the department of cardiology, endovascular and vascular surgery, National Medical Research Center of Endocrinology, Moscow, Russia Ekaterina N. Bondarenko, M.D., Ph.D., doctor of sciences, chief scientist of the department of cardiology, endovascular and vascular surgery, National Medical Research Center of Endocrinology, Moscow, Russia Kirov Military Medical Academy, Saint Petersburg, Russia Agafonov, M.D., Ph.D., lecturer of the department of military-field surgery, S.M. Kirov Military Medical Academy, Saint Petersburg, Russia Pavel V. Khalimov, M.D., Ph.D., doctor of sciences, professor, head of the department of military-field surgery, deputy chief physician, S.M. Mamedov, M.D., Ph.D., doctor of sciences, professor, head of the laboratory of interdisciplinary approach for prevention of chronic non-infectious diseases, National Research Centre for Preventive Medicine, Moscow, Russia. ![]() Kirov Military Medical Academy, Saint Petersburg, Russia 3 National Medical Research Center of Endocrinology, Moscow, Russia 4 Gerontological Clinical Research Center, Pirogov Russian National Research Medical University, Mamedov M.N.1*, Khalimov Yu.Sh.2, Agafonov P.V.2, Bondarenko I.Z.3, Kalashnikov V.Yu.3, Dudinskaya E.N.4, Runikhina N.K.4, Kotovskaya Yu.V.4, Tkacheva O.N.4ġ National Research Center for Preventive Medicine of the Ministry of Healthcare of the Russian Federation,Ģ S.M. Statement by the American Diabetes Association: comments of Russian experts International Heart and Vascular Disease Journal Volume 5, Number 16, December 2017 This article contains the comments of leading Russian experts on key points of the new position statement of ADA. Published document consists of several parts that include detection, screening and diagnostics of AH, information about target BP levels, AH treatment with lifestyle change and pharmacological therapy, management of several groups of patients and treatment of resistant hypertension. It has been proved that BP control with antihypertensive therapy reduces the frequency of cardiovascular diseases related to atherosclerosis, heart failure, and microvascular complications. AH is one of the main risk factors in people with DM, and its prevalence depends on many circumstances and reaches 80%. In September 2017 the experts of the American Diabetes Association (ADA) published a new document dedicated to diagnostics and treatment of arterial hypertension (AH) in patients with diabetes mellitus (DM).
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |